Emil Lou, MD,PhD,FACP
@cancerassassin1.bsky.social
Physician-Scientist/Clinical Cancer Biologist/GI Medical Oncologist. In lab: Cancer Cell Biology, uncovering how #TunnelingNanotubes drive ChemoResistance. https://med.umn.edu/dom/divisions/hematology-oncology-and-transplantation/research/emil-lou-lab
#TunnelingNanotubes are membranous extensions of cells that mediate cell contact-dependent intercellular transport of organelles and viruses. In our recent study of SARS-CoV-2 in tissue from patients, we found them in post-infected samples from matched tissue specimens. www.cell.com/iscience/ful...
October 4, 2025 at 1:04 PM
#TunnelingNanotubes are membranous extensions of cells that mediate cell contact-dependent intercellular transport of organelles and viruses. In our recent study of SARS-CoV-2 in tissue from patients, we found them in post-infected samples from matched tissue specimens. www.cell.com/iscience/ful...
GI Cancers took center stage at #ASCO25 (figuratively and literally!). Here, our #OnlyOncs team broke down the details on a Phase III trial in stages I-III pancreatic carcinomas, comparing standard mFOLFIRINOX chemo to PAXG. @shaalanbeg.bsky.social @shrutipatelmd.bsky.social @onclive.bsky.social
June 3, 2025 at 12:35 AM
GI Cancers took center stage at #ASCO25 (figuratively and literally!). Here, our #OnlyOncs team broke down the details on a Phase III trial in stages I-III pancreatic carcinomas, comparing standard mFOLFIRINOX chemo to PAXG. @shaalanbeg.bsky.social @shrutipatelmd.bsky.social @onclive.bsky.social